150 related articles for article (PubMed ID: 32804104)
21. Nephrotic syndrome complicated by idiopathic central diabetes insipidus.
Konomoto T; Tanaka E; Imamura H; Orita M; Sawada H; Nunoi H
Pediatr Nephrol; 2014 May; 29(5):927-30. PubMed ID: 24408226
[TBL] [Abstract][Full Text] [Related]
22. Variability in Oral Desmopressin Dose Requirements in Children with Central Diabetes Insipidus.
Almutlaq N; Eugster EA
J Pediatr; 2021 Dec; 239():228-230. PubMed ID: 34487771
[TBL] [Abstract][Full Text] [Related]
23. Gefitinib Treatment Was Unsuccessful for Central Diabetes Insipidus Due to Pituitary Metastasis of Lung Adenocarcinoma.
Tanaka S; Hirabayashi T; Kimoto M; Hama M; Hachiya T; Gomi K
Intern Med; 2021 Apr; 60(7):1073-1076. PubMed ID: 33162476
[TBL] [Abstract][Full Text] [Related]
24. Transient diabetes insipidus in a preterm neonate and the challenge of desmopressin dosing.
Van der Kaay DC; Van Heel WJ; Dudink J; van den Akker EL
J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):769-71. PubMed ID: 24670345
[TBL] [Abstract][Full Text] [Related]
25. Unusual ischemic kidney injury presenting as slowly declining graft function and successful use of oral desmopressin in a kidney transplant recipient with subclinical central diabetes insipidus.
Kaneko S; Usui J; Kawanishi K; Ishii R; Takahashi K; Suzuki H; Saito C; Oda T; Nagata M; Yamagata K
Clin Nephrol; 2021 Apr; 95(4):208-214. PubMed ID: 33560220
[TBL] [Abstract][Full Text] [Related]
26. [Clinical characteristics of central diabetes insipidus: a retrospective analysis of 230 cases].
Zhang JP; Guo QH; Mu YM; Lyu ZH; Gu WJ; Yang GQ; Du J; Ba JM; Lu JM
Zhonghua Nei Ke Za Zhi; 2018 Mar; 57(3):201-205. PubMed ID: 29518865
[No Abstract] [Full Text] [Related]
27. Delay in desmopressin therapy: Disaster in waiting.
Kroll C; Zandvakili A
J Clin Pharm Ther; 2022 Dec; 47(12):2376-2378. PubMed ID: 36376238
[TBL] [Abstract][Full Text] [Related]
28. Treatment of neonatal diabetes insipidus with desmopressin.
Giacoia GP; Watson S; Karathanos A
South Med J; 1984 Jan; 77(1):75-7. PubMed ID: 6695224
[TBL] [Abstract][Full Text] [Related]
29. [Treatment with sublingual desmopressin in two infants with hydranencephaly and central diabetes insipidus].
Marín GR; Baspineiro B; Vilca I
Arch Argent Pediatr; 2018 Feb; 116(1):e93-e97. PubMed ID: 29333830
[TBL] [Abstract][Full Text] [Related]
30. Idiopathic central diabetes insipidus presenting in a very low birth weight infant successfully managed with lyophilized sublingual desmopressin.
Hanta D; Törer B; Temiz F; Kılıçdağ H; Gökçe M; Erdoğan Ö
Turk J Pediatr; 2015; 57(1):90-3. PubMed ID: 26613228
[TBL] [Abstract][Full Text] [Related]
31. Desmopressin duration of antidiuretic action in patients with central diabetes insipidus.
Juul KV; Bichet DG; Nørgaard JP
Endocrine; 2011 Aug; 40(1):67-74. PubMed ID: 21626284
[TBL] [Abstract][Full Text] [Related]
32. Central diabetes insipidus in five cats: clinical presentation, diagnosis and oral desmopressin therapy.
Aroch I; Mazaki-Tovi M; Shemesh O; Sarfaty H; Segev G
J Feline Med Surg; 2005 Dec; 7(6):333-9. PubMed ID: 15927500
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study.
Arima H; Oiso Y; Juul KV; Nørgaard JP
Endocr J; 2013; 60(9):1085-94. PubMed ID: 23811987
[TBL] [Abstract][Full Text] [Related]
34. Neurosarcoidosis-associated central diabetes insipidus masked by adrenal insufficiency.
Non L; Brito D; Anastasopoulou C
BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25612752
[TBL] [Abstract][Full Text] [Related]
35. Clinical characteristics and management of cranial diabetes insipidus in infants.
Karthikeyan A; Abid N; Sundaram PC; Shaw NJ; Barrett TG; Högler W; Kirk JM
J Pediatr Endocrinol Metab; 2013; 26(11-12):1041-6. PubMed ID: 23751384
[TBL] [Abstract][Full Text] [Related]
36. Septo-optic dysplasia and associations with amyoplasia and gastroschisis.
Kamien B; Zankl A; Gabbett M
Birth Defects Res A Clin Mol Teratol; 2010 Jun; 88(6):497-501. PubMed ID: 20589918
[TBL] [Abstract][Full Text] [Related]
37. Management of central diabetes insipidus with oral desmopressin in a patient with ectrodactyly and cleft lip/palate (ECP) syndrome.
Ozaydin E; Aycan Z; Yusufoğlu AM; Cetinkaya E; Ergen S; Unal S; Köse G
Turk J Pediatr; 2009; 51(1):89-93. PubMed ID: 19378901
[TBL] [Abstract][Full Text] [Related]
38. Management of central diabetes insipidus with oral desmopressin in a premature neonate.
Atasay B; Berberoğlu M; Günlemez A; Evliyaoğlu O; Adiyaman P; Unal S; Arsan S; Ocal G
J Pediatr Endocrinol Metab; 2004 Feb; 17(2):227-30. PubMed ID: 15055359
[TBL] [Abstract][Full Text] [Related]
39. Use of subcutaneous DDAVP in infants with central diabetes insipidus.
Blanco EJ; Lane AH; Aijaz N; Blumberg D; Wilson TA
J Pediatr Endocrinol Metab; 2006 Jul; 19(7):919-25. PubMed ID: 16995572
[TBL] [Abstract][Full Text] [Related]
40. Long-term hormone replacement treatment in a horse with central diabetes insipidus.
Durie I; van Galen G
J Vet Intern Med; 2020 Mar; 34(2):1013-1017. PubMed ID: 31960998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
